BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Scott + Scott, LLC Announces Investigation Regarding Chiron Corporation (CHIR) Flu Vaccine Suspension


10/19/2005 5:11:50 PM

The law firm of Scott + Scott, LLC, (www.scott-scott.com or contact nrothstein@scott-scott.com) with substantial securities litigation experience and pension/ERISA (Employee Retirement Income Security Act) experience has been asked to investigate claims on behalf of shareholders who have been affected by the recent problems at the Chiron Corporation (Nasdaq: CHIR). Chiron is one of the world's top biotech firms. It focuses on three areas: biopharmaceuticals, vaccines, and blood testing. The vaccines unit sells pediatric, flu, and adult infection vaccines; its blood-testing products detect HIV and other viruses. Novartis, one of Chiron's R&D partners, owns a 42% stake in the company.

Read at BioSpace.com


   
Influenza
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->